WL
I wish you would do some research:
"The patch formulation, patch prototyping and in vitro testing components of this program were conducted in the USA. Following the completion of the formulation and stability studies in July 2009, the Company provided a range of Dermaportation fields and ETP materials for direct comparative testing against the established gel product. Over the four-week study period, Dermaportation and ETP materials were optimised to the Azopharma formulation and data on the rates of penetration through human epidermis were generated. The level of enhanced delivery over and above that of the established gel product met the Company?s expectations for both Dermaportation and ETP technologies. The study results have been released to the market via an announcement dated 1 October 2009." form prospectus 6.3 page 16
The drug was provided and the delivery methodology (i.e through the skin) was enhanced
- Forums
- ASX - By Stock
- WFL
- shareholder update
shareholder update, page-65
-
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable